Dawn Hershman

Dawn Hershman at Columbia has made contributions to cancer supportive care, including research on chemotherapy-induced peripheral neuropathy (CIPN) and integrative oncology approaches including acupuncture. Her randomized trials on acupuncture for aromatase inhibitor-induced musculoskeletal symptoms demonstrated efficacy in a high-quality trial design, contributing to evidence-based integrative oncology. Her work addresses disparities in supportive care access across racial and socioeconomic groups.